AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET
Company Participants
Jessica Ekeberg – Director, Investor Relations
Jim Corbett – Chief Executive Officer
David O’Toole – Chief Financial Officer
Conference Call Participants
Brooks O’Neil – Lake Street Capital Markets
Ross Osborne – Cantor Fitzgerald
Eric Anderson – TD Cowen
John Hester – Bell Potter
Chris Kallos – MST Access
Operator
Good day and thank you for standing by. Welcome to the AVITA Medical, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question and answer session. [Operator Instructions] Please be advised that today’s conference call is being recorded.
I would now like to hand the conference over to your first speaker today, Jessica Ekeberg. Please go ahead.
Jessica Ekeberg
Thank you, Operator. Welcome to AVITA Medical’s third quarter 2024 earnings call. Joining me on today’s call are Jim Corbett, Chief Executive Officer; and David O’Toole, Chief Financial Officer. Today’s earnings release and presentation are available on our website, www.avitamedical.com, under the Investor Relations section. Before we begin, I’d like to remind you that this call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results to differ materially from any expectations expressed or implied by the forward-looking statements. Please review our most recent filings with the SEC for comprehensive descriptions of the risk factors. Any forward-looking statements provided during this call are based on management’s expectations as of today.
I will now turn the call over to Jim for his comments.
Jim Corbett
Thank you, Jessica, and good afternoon, everyone. If you’ve been on our previous calls, you
